Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.

Lee JM, Kim HW, Lee EG, Park Y, Jung SS, Kim JW, Oh JY, Lee H, Kim SH, Kim SH, Lyu J, Kwon SJ, Jeong YJ, Koo HK, Chae G, Kim JS, Min J

Open source

DOI: 10.1007/s10096-026-05629-8
Published: 2026 Aug 13
Container: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10096-026-05629-8,
  title = {Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.},
  author = {Lee JM and Kim HW and Lee EG and Park Y and Jung SS and Kim JW and Oh JY and Lee H and Kim SH and Kim SH and Lyu J and Kwon SJ and Jeong YJ and Koo HK and Chae G and Kim JS and Min J},
  year = {2026},
  journal = {European journal of clinical microbiology \& infectious diseases : official publication of the European Society of Clinical Microbiology},
  doi = {10.1007/s10096-026-05629-8},
  url = {https://doi.org/10.1007/s10096-026-05629-8}
}

RIS

TY  - JOUR
TI  - Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.
AU  - Lee JM
AU  - Kim HW
AU  - Lee EG
AU  - Park Y
AU  - Jung SS
AU  - Kim JW
AU  - Oh JY
AU  - Lee H
AU  - Kim SH
AU  - Kim SH
AU  - Lyu J
AU  - Kwon SJ
AU  - Jeong YJ
AU  - Koo HK
AU  - Chae G
AU  - Kim JS
AU  - Min J
PY  - 2026
JO  - European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
DO  - 10.1007/s10096-026-05629-8
UR  - https://doi.org/10.1007/s10096-026-05629-8
ER  -

APA

JM, L., HW, K., EG, L., Y, P., SS, J., JW, K., JY, O., H, L., SH, K., SH, K., J, L., SJ, K., YJ, J., HK, K., G, C., JS, K., & J, M. (2026). Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. https://doi.org/10.1007/s10096-026-05629-8

Source records

pubmed · retrieved 2026-09-27T15:41:50.784Z